SLC1A2 and schizophrenia: Interestingly, chronic haloperidol treatment down regulate EAAT2 in the cingulate- and frontal cortex in rats [45], indicating that decreased EAAT2 levels rather may reflect a beneficial condition following the antipsychotic treatment of schizophrenia.